Plasma cytokines in obese women with polycystic ovary syndrome, before and after metformin treatment
Authors:
- Anna Bohdanowicz-PawlakABAnna Bohdanowicz-Pawlak
- Andrzej MilewiczAMAndrzej Milewicz
- Jadwiga SzymczakJSJadwiga Szymczak
- Grażyna Bednarek-TupikowskaGBGrażyna Bednarek-Tupikowska
- Marek DemissieMDMarek Demissie
- 1 January 2008
- journal article
- Published by Taylor & Francis in Gynecological Endocrinology
- Vol. 24 (7) , 378-384
Abstract
Most research confirms that metformin therapy has a positive influence on cardiovascular risk factors (CVRF) such as dyslipidemia, insulin resistance and hyperandrogenism in polycystic ovary syndrome (PCOS). The aims of the present study were to establish other CVRF, such as plasma adiponectin, tumor necrosis factor-alpha (TNFalpha), interleukin-6 (IL-6) and C-reactive protein (CRP) levels, in obese premenopausal women with PCOS and to investigate the effect of metformin treatment on these factors. The study group consisted of 29 PCOS woman with body mass index (BMI) >25 kg/m(2). They were treated over 6 months with 500 mg metformin twice daily. Twenty-nine healthy individuals matched for age and BMI were controls. Adiponectin, TNFalpha, IL-6 and CRP levels were examined in all PCOS (before and after treatment) and control women. In the PCOS group significantly lower plasma adiponectin and TNFalpha levels were observed, whereas there were no differences in plasma IL-6 and CRP levels between PCOS and control groups. Plasma adiponectin increased significantly after metformin treatment, but levels of inflammatory factors did not change.Keywords
This publication has 39 references indexed in Scilit:
- Plasma interleukin 6 levels are elevated in polycystic ovary syndrome independently of obesity or sleep apneaMetabolism, 2006
- Adiponectin is an independent determinant of insulin resistance in women with polycystic ovary syndromeGynecological Endocrinology, 2006
- Adiponectin – journey from an adipocyte secretory protein to biomarker of the metabolic syndromeJournal of Internal Medicine, 2005
- Serum and follicular fluid cytokines in polycystic ovary syndrome during stimulated cyclesObstetrics & Gynecology, 2003
- Markers of Inflammation and Cardiovascular DiseaseCirculation, 2003
- C-Reactive Protein and Other Markers of Inflammation in the Prediction of Cardiovascular Disease in WomenNew England Journal of Medicine, 2000
- Novel Modulator for Endothelial Adhesion MoleculesCirculation, 1999
- C-Reactive Protein in Healthy Subjects: Associations With Obesity, Insulin Resistance, and Endothelial DysfunctionArteriosclerosis, Thrombosis, and Vascular Biology, 1999
- Adipose Expression of Tumor Necrosis Factor-α: Direct Role in Obesity-Linked Insulin ResistanceScience, 1993
- Evidence for different effects of soluble TNF-receptors on various TNF measurements in human biological fluidsThe Lancet, 1991